Tanshinone Ⅱ A, the major lipophilic component of Danshen, promotes neuronal differentiation through

来源 :中国药理学会第十三次全国学术大会 | 被引量 : 0次 | 上传用户:shanzhaokai
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Danshen has been used in stroke treatment for thousands of years in China.However, the underlying mechanism still remains elusive.Neuron loss is the cardinal feature of stroke.Stimulating endogenous neurogenesis, especially neuronal differentiation, might potentially provide therapeutic effects to these diseases.To interpret Danshen s diseasemodifying effects, the effects of tanshinone Ⅱ A (T Ⅱ A), the major lipophilic component of Danshen, on neuronal differentiation in rat PC12 pheochromocytoma cells and the rat embryonic cortical neural stem cells (NSCs) were observed.PC12 cells and NSCs were incubated with T ⅡA for 7 days.To detect the neuronal differentiation, GAP43 expression was detected by western blots assay and βtubulin Ⅲ expression was detected by immunocytochemical staining.Results showed that T Ⅱ A dosedependently promoted neuronal differentiation.T Ⅱ A activated mitogenactivated protein kinase 42/44 (MAPK42/44) and its downstream transcription factor, cAMP response elementbinding protein (CREB).In addition, T Ⅱ A upregulated the expressions of brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF).The MEK inhibitor and the antagonist to the receptors of NGF and BDNF could partially attenuate the differentiation effects, indicating that MAPK42/44 mediated BDNF and NGF signals were involved in T Ⅱ A s differentiation effects.Caveolin1 (CAV1), the major functional protein of membrane caveolae, plays critical roles in the endocytosis of exogenous materials.CAV1, which was activated by T Ⅱ A, might help T ⅡA transport across cell membrane to initiate its differentiation effects.It was proven by the evidences that suppressing the function of caveolin inhibited the differentiation effects of T Ⅱ A.Therefore, it was concluded that T Ⅱ A promoted neuronal differentiation partially through MAPK42/44 mediated BDNF and NGF signals in a caveolaedependent manner.
其他文献
Suppression of excessive inflammation can ameliorate blood brain barrier (BBB) injury, which shows therapeutic potential for clinical treatment of brain injury induced by stroke superimposed on system
Aim Angiotensin Ⅱ (AngⅡ) induces vascular smooth muscle cell (VSMC) migration and growth, which is responsible for vascular remodeling during some cardiovascular diseases.It has been demonstrated to a
Background and Aim Vascular smooth muscle cell (SMC) phenotype change is a hallmark of vascular remodeling, which can be regulated via MicroRNAs (miRNAs)dependent mechanism.We recently identified Asym
TP53, encoding a wellknown tumor suppressor p53, plays essential roles in tumor initiation and progression, and is frequently mutated in lung cancer.However, pharmacological stabilization and reactiva
Aim It is well known that menopause could worsen agerelated ventricular concentric remodeling and increased incidence of arrhythmias following estrogen (E2) deficiency.However, the underlying mechanis
Aim Autosomal dominant polycystic kidney disease (ADPKD) affects between 1 in 400 to 1000 individuals and is characterized by massive enlargement of fluidfilled cysts of renal tubular origin that comp
Progressive beta cell apoptosis is a major cause leading to a decline in beta cell mass in type 2 diabetes.While it has been discovered that mitochondrial protein Sirtuin 5 (SIRT5) functions as the pr
Currently, accumulating studies indicated that upregulation of glycogen synthase kinase3β (GSK3β)played an important role in depression pathogenesis.Our previous study demonstrated that ammoxetine, a
Aim Aging is the dominant risk factor for cardiovascular disease.Recently, we have shown that genomic instability, a causative mechanism of aging in general, induced by functional mutation of the ERCC
会议
Aim DL08052 is a novel Rhokinases inhibitor which has been found to have potent cardiovascular effects.In the present research, we aimed to study the potential of DL08052 in the treatment of pulmonary